Harpreet Singh

8.3k total citations · 2 hit papers
162 papers, 5.6k citations indexed

About

Harpreet Singh is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Harpreet Singh has authored 162 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 29 papers in Oncology and 25 papers in Infectious Diseases. Recurrent topics in Harpreet Singh's work include Cancer Immunotherapy and Biomarkers (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Immunotherapy and Immune Responses (11 papers). Harpreet Singh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Immunotherapy and Immune Responses (11 papers). Harpreet Singh collaborates with scholars based in India, United States and Germany. Harpreet Singh's co-authors include Gajendra P. S. Raghava, Reto Huber, Fabio Ferrarelli, Steve K. Esser, Giulio Tononi, Marcello Massimini, Carl A. Gregory, Darwin J. Prockop, Richard Pazdur and Anthony S. Perry and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Harpreet Singh

151 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breakdown of Cortical Effective Connectivity During Sleep

2005 1.1k citations Harpreet Singh et al. profile →
ProPred: prediction of HLA-DR binding sites

2001 705 citations Harpreet Singh, Gajendra P. S. Raghava profile →

Peers

Countries citing papers authored by Harpreet Singh

Since Specialization

Citations

This map shows the geographic impact of Harpreet Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harpreet Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harpreet Singh more than expected).

Fields of papers citing papers by Harpreet Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harpreet Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harpreet Singh. The network helps show where Harpreet Singh may publish in the future.

Co-authorship network of co-authors of Harpreet Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Harpreet Singh. A scholar is included among the top collaborators of Harpreet Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harpreet Singh. Harpreet Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Next Generation Sequencing (tNGS) for detection of drug-resistant tuberculous meningitis: Is this sequencing technology ready for prime time? 2024 ·Indian Journal of Medical Microbiology ·Priti Kambli, Kanchan Ajbani, (unknown), (unknown), Anjali Shetty, (unknown), (unknown), Harpreet Singh, Camilla Rodrigues	1
2	FDA analysis of immune checkpoint inhibitors in combination with vascular endothelial growth factor tyrosine kinase inhibitors in the second-line treatment of patients with advanced non-small cell lung cancer. 2024 ·Journal of Clinical Oncology ·(unknown), Gautam U. Mehta, Paz J. Vellanki, Erin Larkins, Paul G. Kluetz, Harpreet Singh	0
3	Identification of host immune-related biomarkers in active tuberculosis: A comprehensive analysis of differentially expressed genes 2024 ·Tuberculosis ·(unknown), Gajendra Pratap Singh, Mamtesh Singh, Harpreet Singh	3
4	The role of yellow enhancement in laparoscopy 2024 ·British journal of surgery ·(unknown), Harpreet Singh, (unknown), (unknown), (unknown), Sharmini Su Sivarajah, (unknown), Fung Joon Foo, (unknown), (unknown), (unknown), Frederick H. Koh	0
5	Tracing the COVID-19 spread pattern in India through a GIS-based spatio-temporal analysis of interconnected clusters 2024 ·Scientific Reports ·Mousumi Gupta, (unknown), (unknown), (unknown), (unknown), (unknown), Harpreet Singh, Amlan Gupta	1
6	Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis 2023 ·Frontiers in Public Health ·(unknown), Yogendra Bhaskar, (unknown), Shweta Rana, Prabudh Goel, Sujeet Kumar, K. C. Gouda, Harpreet Singh	9
7	Anti‐microbial resistance and aging—A design for evolution 2023 ·PubMed ·(unknown), (unknown), Harpreet Singh, Shweta Rana, Deepak Kumar Saini	0
8	Smokeless tobacco consumption induces dysbiosis of oral mycobiome: a pilot study 2022 ·Applied Microbiology and Biotechnology ·Mohammad Sajid, Pragya Sharma, Sonal Srivastava, Roopa Hariprasad, Harpreet Singh, Mausumi Bharadwaj	10
9	India’s Opportunities and Challenges in Establishing a Twin Registry: An Unexplored Human Resource for the World’s Second-Most Populous Nation 2022 ·Twin Research and Human Genetics ·Ruby Dhar, Shweta Rana, (unknown), (unknown), J. B. Sharma, (unknown), Krishna R. Kalari, Harpreet Singh, Subhradip Karmakar	1
10	Inter-laboratory testing as a strategy for external quality assessment for qualitative detection of SARS-CoV-2 by real-time RT-PCR testing in India 2022 ·The Indian Journal of Medical Research ·Harmanmeet Kaur, (unknown), Neeraj Aggarwal, Nivedita Gupta, (unknown), Neetu Vijay, Swati Gupta, (unknown), (unknown), (unknown), Harpreet Singh	1
11	Importing oncology trials from China: a bridge over troubled waters? 2022 ·The Lancet Oncology ·Harpreet Singh, Richard Pazdur	11
12	External quality assessment of COVID-19 real time reverse transcription PCR laboratories in India 2022 ·PLoS ONE ·Harmanmeet Kaur, (unknown), Nivedita Gupta, Neeraj Aggarwal, Lucky Sangal, Varsha Potdar, (unknown), Jitendra Narayan, Swati Gupta, (unknown), Neetu Vijay, Harpreet Singh, Jasmine Kaur, (unknown), (unknown), Priya Abraham, Vasanthapuram Ravi	8
13	Role of Microglia and Astrocytes in Spinal Cord Injury Induced Neuropathic Pain 2021 ·Annals of Neurosciences ·Gurwattan S. Miranpuri, (unknown), (unknown), (unknown), Shweta Modgil, (unknown), (unknown), (unknown), (unknown), Harpreet Singh, (unknown), Jagtar Singh, Akshay Anand	27
14	Geo-prioritization framework for COVID-19 vaccine allocation in India 2021 ·Vaccine ·(unknown), (unknown), (unknown), Shashwat Shivam, Harpreet Singh	1
15	Identification of potential drug targets and vaccine candidates in Clostridium botulinum using subtractive genomics approach 2019 ·Bioinformation ·(unknown), Amit Katiyar, (unknown), Harpreet Singh, (unknown)	17
16	National Burden Estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data 2019 ·The Lancet Global Health ·Geetha R. Menon, Lucky Singh, Palak Sharma, (unknown), S. Sharma, (unknown), Harpreet Singh, Adinarayanan Srividya, Vasna Joshua, Vaitheeswaran Kulothungan, Jeetendra Yadav, (unknown), Shaza A. Fadel, Wilson Suraweera, M. Vishnu Vardhana Rao, Rupinder Singh Dhaliwal, Rehana Begum, Prabha Sati, Dean T. Jamison, Prabhat Jha	85
17	Precursor of prostate‐specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases 2009 ·British Journal of Urology ·David Hull, Jun Ma, Harpreet Singh, Deloar Hossain, Junqi Qian, David G. Bostwick	7
18	The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone Marrow 2003 ·Journal of Biological Chemistry ·Carl A. Gregory, Harpreet Singh, Anthony S. Perry, Darwin J. Prockop	234
19	Detection of Orientation of MHC Class II Binding Peptides Using Bioinformatics Tools 2002 ·Harpreet Singh, Gajendra P. S. Raghava	2
20	Conjugation in Archaea: Frequent Occurrence of Conjugative Plasmids inSulfolobus 1998 ·Plasmid ·David Prangishvili, Sonja‐Verena Albers, Ingelore Holz, Hans Peter Arnold, Kenneth M. Stedman, Tino Klein, Harpreet Singh, (unknown), (unknown), Jakob K. Kristjánsson, Wolfram Zillig	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact